Status:

COMPLETED

Use of Methacetin Breath Test to Predict Liver Failure in Patients With Cirrhosis

Lead Sponsor:

Virginia Commonwealth University

Collaborating Sponsors:

Meridian Bioscience, Inc.

Conditions:

Cirrhosis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The methacetin breath test (MBT) is a non-invasive liver function test which measures the ability of the liver to metabolize a tracer dose of a compound to carbon dioxide, which is exhaled. The study ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Being considered for placement or already on the liver transplantation waiting list
  • Cirrhosis caused by any cause of chronic liver disease.
  • Age \> 18 years
  • Exclusion criteria:
  • Known or suspected hepatocellular carcinoma
  • Prior TIPS placement
  • Severe congestive heart failure
  • Severe pulmonary hypertension
  • Uncontrolled diabetes mellitus (HBA1C \>9.5%)
  • Any autoimmune disorder, which is currently being treated with prednisone or any other immune suppressive medication.
  • Previous surgical bypass surgery for morbid obesity (BMI \>45)
  • Extensive small bowel resection
  • Patients currently receiving total parenteral nutrition if they have contraindications to oral drugs
  • Women who are pregnant
  • Patients who are allergic to acetaminophen/ paracetamol or any other related medications
  • Patients with an acute current exacerbation of chronic obstructive pulmonary disease or bronchial asthma.
  • Patients that are taking hepatotoxin drugs
  • Patient, based on the opinion of the investigator, should not be enrolled into this study
  • Patient is unable or unwilling to sign informed consent.
  • Patients that are participating in other clinical trials evaluating experimental treatments or procedures

Exclusion

    Key Trial Info

    Start Date :

    March 1 2010

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    July 1 2012

    Estimated Enrollment :

    165 Patients enrolled

    Trial Details

    Trial ID

    NCT01157845

    Start Date

    March 1 2010

    End Date

    July 1 2012

    Last Update

    May 16 2014

    Active Locations (4)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (4 locations)

    1

    Henry Ford Health System

    Detroit, Michigan, United States, 48202

    2

    Medical University of South Carolina

    Charleston, South Carolina, United States, 29425

    3

    Virginia Commonwealth University Medical Center

    Richmond, Virginia, United States, 23298

    4

    Hadassah Medical Center

    Jerusalem, Israel, Israel, 91120